IMMX
Immix Biopharma, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
—
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
Immix Biopharma, Inc.
Expected move
InputsNext report
Last report
—
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
Fund move
Fund move
No thesis.
Immix Biopharma, Inc.
7.67
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Jupiter TopcoJupiter Topco | $100.8M | 17.36% | — | |
| 2 | Saturn V Capital ManagementSaturn V | $48.0M | 8.27% | +26.12% | |
| 3 | Eventide Asset ManagementEventide | $40.1M | 6.91% | +52.65% | |
| 4 | State StreetState Streetindex-like | $30.9M | 5.32% | +1461.64% | |
| 5 | BlackRockBlackRockindex-like | $30.8M | 5.31% | +538.37% | |
| 6 | Deep Track CapitalDeep Track Capital | $28.6M | 4.93% | new | |
| 7 | Vanguard Capital ManagementVanguardindex-like | $25.8M | 4.45% | +40.22% | |
| 8 | Opaleye ManagementOpaleye | $24.2M | 4.16% | new | |
| 9 | Millennium ManagementMillennium | $21.3M | 3.67% | +18.07% | |
| 10 | UBS GroupUBS | $20.0M | 3.45% | +2427.35% | |
| 11 | Marshall WaceMarshall Wace | $18.5M | 3.19% | +9.34% | |
| 12 | T. Rowe Price AssociatesT. Rowe Price | $17.9M | 3.09% | +319.26% | |
| 13 | Wellington Management GroupWellington | $15.2M | 2.62% | new | |
| 14 | Great Point PartnersGreat Point Partners | $13.2M | 2.27% | +265.04% | |
| 15 | Geode Capital ManagementGeodeindex-like | $12.4M | 2.13% | +159.20% | |
| 16 | Velan Capital Investment ManagementVelan Capital | $11.2M | 1.93% | +46.62% | |
| 17 | BleichroederBleichroeder | $10.3M | 1.78% | 0.00% | |
| 18 | Logos Global ManagementLogos Global | $10.3M | 1.78% | −18.37% | |
| 19 | Franklin ResourcesFranklin Resources | $10.0M | 1.72% | +0.01% | |
| 20 | Burkehill Global ManagementBurkehill Global | $5.6M | 0.97% | +85.00% | |
| 21 | Citadel AdvisorsCitadel | $5.5M | 0.95% | +1039.97% | |
| 22 | Ameriprise FinancialAmeriprise Financial | $5.3M | 0.92% | new | |
| 23 | Blue Owl Capital HoldingsBlue Owl Capital | $4.5M | 0.78% | −20.09% | |
| 24 | Northern TrustNorthern Trustindex-like | $4.3M | 0.74% | +202.43% | |
| 25 | Balyasny Asset ManagementBalyasny | $4.3M | 0.74% | new |
109 managers report $580.8M of Immix Biopharma on form 13F for the quarter ended Jun 30 '26. 17 of them hold 80% of it; Jupiter Topco is largest at 17.36%.
Expected move
Inputsspot 7.68exp Nov 20ATM strike 7.5ATM straddle 1.43IV 98%